Lipomics Technologies, Inc. to Launch Diagnostic Development Program in Liver Disease

Published: Mar 17, 2008

WEST SACRAMENTO, Calif., Mar. 17, 2008 - Lipomics Technologies, Inc., a privately held company that specializes in developing diagnostics for managing metabolic and cardiovascular disease, announced today that it is launching an effort to validate its proprietary biomarkers for fatty liver disease.

Back to news